¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"positive contrast orbitography"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • continuous positive airway pressure
    Áö¼Ó±âµµ¾ç¾Ð
  • continuous positive pressure breathing
    Áö¼Ó¼º¾ç¾ÐÈ£Èí(¹ý)
  • chromatin-positive
    ¿°»öÁú¾ç¼º-
  • false positive
    °ÅÁþ¾ç¼º, °¡¾ç¼º
  • false positive reaction
    °ÅÁþ¾ç¼º¹ÝÀÀ, °¡¾ç¼º¹ÝÀÀ
  • gram-positive
    ±×¶÷¾ç¼º-
  • gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • intermittent positive pressure breathing
    °£Çæ¾ç¾ÐÈ£Èí
  • intermittent positive pressure ventilation
    °£Çæ¾ç¾Ðȯ±â(¹ý)
  • positive
    1. ¾ç¼º- 2. ±àÁ¤-
  • positive acceleration
    ¾ç¼º°¡¼Óµµ
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive convergence
    ¾ç¼º´«¸ðÀ½
  • positive conversion
    ¾ç¼ºÀüȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • automatic intermittent positive pressure
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • automatic intermittent positive pressure respirator
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • positive acceleration
    ¾ç¼º°¡¼Ó
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • continuous positive pressure breathing
    Áö¼Ó¼º¾ç¾ÐÈ£Èí(¹ý)
  • Gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • intermittent positive pressure breathing
    °£Çæ¾ç¾ÐÈ£Èí
  • positive pressure breathing
    ¾ç¾ÐÈ£Èí(¹ý)
  • continuous positive airway pressure
    Áö¼Ó¼º±âµµ¾ç¾Ð
  • positive convergence
    ¾ç¼º´«¸ðÀ½
  • positive conversion
    ¾çÀü
  • positive declination
    ¿Üȸ¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive airway pressure
    ±âµµ¾ç¾Ð(ѨԳ åÕäâ).
  • positive balance
    ¾ç¼º¼öÁö.
  • positive charge
    ¾çÀüÇÏ(åÕï³ùÃ).
  • positive chronotropic
    ½É¹Úµ¿Áõ°¡.
  • positive chronotropy
    ½É¹Úµ¿¼öÃËÁø<Ç×Áø>(ÀÛ¿ë).
  • positive colloid
    ¾ç¼ºÄÝ·ÎÀ̵å, Á¤(ïá)ÄÝ·ÎÀ̵å.
  • positive column
    ¾ç(±¤)ÁÖ(åÕÎÃñº).
  • positive conditioned reflex
    ¾ç¼ºÁ¶°Ç¹Ý»ç(¡­ðÉËìÚãÞÒ).
  • positive convergence
    ¾ç¼º´«¸ðÀ½, ¾ç¼ºÆøÁÖ(¡­ÜßñÍ).
  • positive conversion
    ¾çÀü(È­)
  • positive crystal
    ¾ç¼º°áÁ¤(åÕàõÌ¿ïÜ).
  • positive declination
    ¿Üȸ¼±
  • positive dromotropy
    (½É)º¯Á¶ÃËÁø<Ç×Áø>(ÀÛ¿ë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dynamic susceptibility contrast technique
    ¿ªµ¿ ÀÚÈ­À² ´ëÁ¶ ±â¹ý
  • gadolinium (Gd) based contrast agent
    °¡µ¹¸®´½ Á¶¿µÁ¦
  • good contrast
    ¶Ñ·ÇÇÑ ´ëÁ¶µµ
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
  • magnetic transfer contrast (MTC)
    ÀÚÈ­ Àü´Þ ´ëÁ¶µµ
  • microscope, phase-contrast
    À§»óÂ÷Çö¹Ì°æ
  • negative contrast medium
    À½¼º Á¶¿µÁ¦
  • opaque enema =barium e., contrast e.
    ¹æ»ç Á¶¿µÁÖÀå(ðãç¯ñ¼ ).
  • phase contrast
    À§»ó ´ëÁ¶
  • phase contrast (PC) MR angiography
    À§»ó ´ëÁ¶ ÀÚ±â°ø¸í Ç÷°üÁ¶¿µ¼ú
  • phase contrast microscopy
    À§»óÂ÷(êÈßÓó¬)Çö¹Ì°æ°Ë»ç
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • phase-contrast microscopy
    À§»óÂ÷Çö¹Ì°æ
  • pre contrast enhanced image
    Á¶¿µ Áõ°¡Àü ¿µ»ó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • non-ionic contrast medium
    ºñÀ̿¼º Á¶¿µÁ¦
  • phase contrast
    À§»ó´ëÁ¶
  • phase contrast MR angiography
    À§»ó´ëÁ¶ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ¼ú
  • pre-contrast enhanced image
    Á¶¿µÁõ°­Àü¿µ»ó
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • T1 contrast
    T1´ëÁ¶µµ
  • T2 contrast
    T2´ëÁ¶µµ
  • tissue contrast
    Á¶Á÷´ëÁ¶µµ
  • water soluble contrast media
    ¼ö¿ë¼ºÁ¶¿µÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CNR cannabinoid receptor; Center for Nursing Research; contrast-to-noise ratio; Council of Nurse Researc...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
CV cardiac volume; cardiovascular; carotenoid vesicle; cell volume; central venous; cephalic vein; cere...
CVG contrast ventriculography; coronary venous graft; cutis verticis gyrata
DCBE double contrast barium enema
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CNR Contrast-to-Noise Ratio
C/N Contrast-to-noise
C/N Contrast-to-noise ratio
DIC Differential Interference Contrast
DCBE Double contrast barium enema
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • positive after potential
    ¾ç¼º ÈÄÀüÀ§
  • positive airway pressure
    ±âµµ ¾ç¾Ð
  • positive aspect
    ÁÁÀº Ãø¸é
  • positive behavior
    ±àÁ¤ÀûÀΠŵµ
  • positive charge
    ¾ç ÀüÇÏ
  • positive communication
    ±àÁ¤ÀûÀÎ ´ëÈ­
  • positive convergence
    ¾ç¼º ´«¸ðÀ½, ¾ç¼º ÆøÁÖ
  • positive declination
    ¿Üȸ¼±
  • positive feedback loop
    ¾ç¼º µÇ¸ÔÀÌ±â °í¸®, ¾ç¼º Çǵå¹é °í¸®
  • positive habit history
    ¾ç¼ºÀÇ ½À°ü º´·Â
  • positive jump sign
    ¸í¹éÇÑ µµ¾à Çö»ó
  • positive modeling
    ±àÁ¤ÀûÀÎ º»º¸±â
  • positive occlusal awareness
    °úµµÇÑ ±³ÇÕ ÀνÄ
  • positive pole
    ¾ç±Ø
  • positive pressure
    ¾ç¾Ð, Á¤¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
non-ionic contrast media <radiology> A class of radiographic contrast media which do not ionise in solution, thereby decreasing effective osmolarity and toxicity.
(05 Mar 2000)
successive contrast The visual effect caused by viewing a brightly coloured object and then a gray surface; the latter appears tinged with the complementary colour of the object. Viewing a surface coloured in the complementary colour of the object rather than in gray enhances the colour intensity of the surface.
(05 Mar 2000)
differential interference contrast <technique> A mode of contrast generation in microscopy that yields an image with a shadow relief. The relief reflects the gradient of optical path difference. Differential Interference Contrast, which is a form of interferenc microscopy that uses polarizing beam splitters, can be of the Smith or Nomarski type.
Acronym: DIC
(05 Aug 1998)
double contrast enema After evacuation of a barium enema and injection of air into the rectum, radiographs show fine details of mucosa of the rectum and colon.
(05 Mar 2000)
iodinated contrast A substance that contains iodine that can be injected, swallowed or given as an enema for the purpose of diagnostics. Iodinated contrast is radiopaque. This means that conventional X-rays will highlight the course of the contrast in the body.
(27 Sep 1997)
iodinated contrast material A substance that contains iodine that can be injected, swallowed or given as an enema for the purpose of diagnostics. Iodinated contrast is radiopaque. This means that conventional X-rays will highlight the course of the contrast in the body.
(27 Sep 1997)
CD4-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells.
(12 Dec 1998)
CD8-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector).
(12 Dec 1998)
gram-positive <microbiology> Bacteria that retain the stain or that are resistant to decolourisation by alcohol during Gram's method of staining.
This is a primary characteristic of bacteria whose cell wall is composed of a thick layer of peptidologlycan containing teichoic and lipoteichoic acid complexed to the peptidoglycan.
See: gram-negative
(06 Oct 1997)
gram-positive asporogenous rods <microbiology> A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.
(12 Dec 1998)
gram-positive asporogenous rods, irregular <microbiology> A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive asporogenous rods, regular <microbiology> A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive bacteria <microbiology> Bacteria which retain the crystal violet stain when treated by gram's method.
(12 Dec 1998)
gram-positive bacterial infections <microbiology> Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
(12 Dec 1998)
gram-positive cocci <microbiology> Coccus-shaped bacteria that retain the crystal violet stain when treated by gram's method.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á